MSN Laboratories Private Limited Bortezomib Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Bortezomib Export Records India — #3 Exporter, 97 Shipments, $3.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bortezomib

India Pharmaceutical Trade Intelligence

$21.9M200 Suppliers109 CountriesHS 30049049

ExportsIndia → BRAZIL28.3%India → UNITED STATES25.4%

ImportsITALY → India$200.0K UNITED STATES → India$72.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: EUGIA US

MSN Laboratories Private Limited — Bortezomib Exporter #3 | $3.6M Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Bortezomib Exporter Profile

Indian Pharmaceutical Exporter · #3 for Bortezomib · $3.6M export value · DGFT Verified

MSN Laboratories Private Limited is the #3 Indian exporter of Bortezomib with $3.6M in export value and 97 verified shipments. MSN Laboratories Private Limited holds a 16.4% market share in Bortezomib exports across 20 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Bortezomib Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Bortezomib export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Bortezomib?

Country	Value	Shipments	Share
UNITED STATES	$687.3K	16	27.7%
ISRAEL	$551.8K	12	22.2%
CANADA	$407.2K	9	16.4%
COLOMBIA	$273.1K	10	11.0%

Who Are the Top Buyers of Bortezomib from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	COLOMBIA	$364.4K	14
EVERSANA LIFE SCIENCE SERVICES LLC	UNITED STATES	$300.0K	6
MEDISON PHARMA	ISRAEL	$251.8K	6
MARCAN PHARMACEUTICALS INC	CANADA	$250.0K	5
MSN LABS AMERICAS SAS	COLOMBIA	$184.8K	6
TO THE ORDER	AUSTRALIA	$144.8K	3
AMERICAN HEALTH PACKAGING	UNITED STATES	$123.4K	3
TO THE ORDER OF----	CANADA	$100.0K	2
MEDIHOME LTD	ISRAEL	$100.0K	2
MSN LABS PERU SAC	PERU	$90.4K	4

MSN Laboratories Private Limited supplies Bortezomib to 37 buyers globally. The largest buyer is TO THE ORDER OF (COLOMBIA), followed by EVERSANA LIFE SCIENCE SERVICES LLC (UNITED STATES) and MEDISON PHARMA (ISRAEL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Bortezomib Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
BORTEZOMIB INJECTION 3.5MG/VIAL SINTETICA NDC NO:83090-008-01	$200.0K	4
M/S MSN Pharmaceutical - Bortezomib SDZ	$144.8K	3
MSN PHARMA - BORTEZOMIB INJECTION 3.5MG/	$107.2K	3
MSN PHARMA BORTEZOMIB 3.5MG X 1 UK	$101.9K	3
BORTEZOMIBE MEDOMIE 3.5MG (1 VIAL) MEDOMIE PHARMA-	$101.8K	3
BORTEZOMIB INJECTION 3.5 MG/ VIAL SINTETICA	$100.0K	2
Bortezomib Medomie 3.5mg (1 Vial) Medomie Pharma-	$100.0K	2
BORTEZOMIB INJECTION 3.5MG 1'S BLUEPOINT	$73.4K	2
MIBZO (BORTEZOMIB INJ 3.5MG/VIAL)-CO BATCH NO:CSF01009A	$67.2K	2
MIBZO (BORTEZOMIB INJ 3.5MG/VIAL)-CO	$64.5K	2

MSN Laboratories Private Limited exports 76 distinct Bortezomib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BORTEZOMIB INJECTION 3.5MG/VIAL SINTETICA NDC NO:83090-008-0 with 4 shipments worth $200.0K.

How Does MSN Laboratories Private Limited Compare to Nearest Bortezomib Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	MSN LABORATORIES PRIVATE LIMITED ★	$3.6M	97	20	$37.0K
2	EUGIA PHARMA SPECIALITIES LIMITED	$3.5M	69	10	$50.0K
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.9M	57	5	$50.0K

MSN Laboratories Private Limited ranks #3 among 200 Indian Bortezomib exporters. Average shipment value of $37.0K compared to the market average of $68.4K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Bortezomib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	263	19.0%
SAHAR AIR	229	16.6%
DELHI AIR CARGO ACC (INDEL4)	168	12.1%
DELHI AIR	148	10.7%
HYDERABAD ACC (INHYD4)	82	5.9%
HYDERABAD AIR	82	5.9%
Bombay Air	62	4.5%
Bombay Air Cargo	32	2.3%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Bortezomib Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bortezomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 97 individual customs records matching MSN Laboratories Private Limited exporting Bortezomib, covering 76 formulations to 20 countries via 37 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 498+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bortezomib

Bortezomib

MSN Laboratories Private Limited — Bortezomib Exporter Profile

MSN Laboratories Private Limited — Bortezomib Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Bortezomib?

Who Are the Top Buyers of Bortezomib from MSN Laboratories Private Limited?

What Is India's Total Bortezomib Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Bortezomib Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Bortezomib Exporters?

What Bortezomib Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Bortezomib to Key Markets

United States — FDA

Canada — HC

How Does MSN Laboratories Private Limited Compare to Nearest Bortezomib Exporters?

Which Indian Ports Ship Bortezomib Exports?

What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?

Bortezomib — Export Intelligence Video

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Bortezomib Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bortezomib Export Data from MSN Laboratories Private Limited

Bortezomib Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source